NEW YORK–(BUSINESS WIRE)–#classaction–Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against STAAR Surgical Company (NASDAQ: STAA) on behalf of STAAR stockholders. Our investigation concerns whether STAAR has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
On August 11, 2020, J Capital published a report claiming that STAAR had overstated its sales in China.
On this news, the price of STAAR’s stock fell sharply, to close at $48.25 per share on August 11, 2020.
If you purchased or otherwise acquired STAAR shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato or Marion Passmore by email at [email protected], or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Powered by WPeMatico